Ardelyx (ARDX) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.92% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -4.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.89% |
| Dec 31, 2025 | -27.87% |
| Jun 30, 2025 | 25.05% |
| Mar 31, 2025 | 6.80% |
| Dec 31, 2024 | 27.33% |
| Sep 30, 2024 | 79.82% |
| Jun 30, 2024 | 46.22% |
| Mar 31, 2024 | 31.35% |
| Dec 31, 2023 | 25.94% |
| Sep 30, 2023 | 29.07% |
| Jun 30, 2023 | 34.14% |
| Mar 31, 2023 | 19.59% |
| Dec 31, 2022 | 34.02% |
| Sep 30, 2022 | 27.67% |
| Jun 30, 2022 | 22.62% |
| Mar 31, 2022 | 20.63% |
| Dec 31, 2021 | 11.68% |
| Sep 30, 2021 | -2.50% |
| Jun 30, 2021 | -2.33% |
| Mar 31, 2021 | 1.89% |
| Dec 31, 2020 | -52.17% |
| Sep 30, 2020 | 23.11% |
| Jun 30, 2020 | 19.66% |
| Mar 31, 2020 | 24.89% |
| Dec 31, 2019 | 25.77% |
| Sep 30, 2019 | 17.12% |
| Jun 30, 2019 | 20.95% |
| Mar 31, 2019 | 15.66% |
| Dec 31, 2018 | 11.54% |
| Sep 30, 2018 | 17.71% |
| Jun 30, 2018 | -43.85% |
| Mar 31, 2018 | -23.74% |
| Dec 31, 2017 | 44.22% |
| Sep 30, 2017 | -380.95% |
| Jun 30, 2017 | -67.51% |
| Mar 31, 2017 | 37.70% |
| Dec 31, 2016 | 42.82% |
| Sep 30, 2016 | 7.07% |
| Jun 30, 2016 | -0.82% |